Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 1—January 2021
Research

Territorywide Study of Early Coronavirus Disease Outbreak, Hong Kong, China

Kenneth Siu-Sing Leung, Timothy Ting-Leung Ng, Alan Ka-Lun Wu, Miranda Chong-Yee Yau, Hiu-Yin Lao, Ming-Pan Choi, Kingsley King-Gee Tam, Lam-Kwong Lee, Barry Kin-Chung Wong, Alex Yat Man Ho, Kam-Tong Yip, Kwok-Cheung Lung, Raymond Wai-To Liu, Eugene Yuk-Keung Tso, Wai-Shing Leung, Man-Chun Chan, Yuk-Yung Ng, Kit-Man Sin, Kitty Sau-Chun Fung, Sandy Ka-Yee Chau, Wing-Kin To, Tak-Lun Que, David Ho-Keung Shum, Shea Ping Yip, Wing Cheong Yam, and Gilman Kit-Hang SiuComments to Author 
Author affiliations: The University of Hong Kong, Hong Kong, China (K.S.-S. Leung, K.K.-G. Tam, W.C. Yam); The Hong Kong Polytechnic University, Hong Kong (T.T.-L. Ng, H.-Y. Lao, M.-P. Choi, L.-K. Lee, D.H.-K. Shum, S.P. Yip, G.K.-H. Siu); Pamela Youde Nethersole Eastern Hospital, Hong Kong (A.K.-L. Wu, M.C.-Y. Yau, K.-C. Lung); United Christian Hospital, Hong Kong (B.K.-C. Wong, E.Y.-K. Tso, K.S.-C. Fung, S.K.-Y. Chau); Princess Margaret Hospital, Hong Kong (A.Y.-M. Ho, W.-S. Leung, M.-C. Chan, W.-K. To); Tuen Mun Hospital, Hong Kong (K.-T. Yip, Y.-Y. Ng, K.-M. Sin, T.-L. Que); Ruttonjee Hospital, Hong Kong (R.W.-T. Liu)

Main Article

Figure 1

Demographics of coronavirus disease patients, Hong Kong, February 2020. Rectangular boxes indicate men or boys and stadium-shaped boxes indicate women or girls. Travel history within the 14-day incubation period before symptom onset is highlighted in cyan for local case without travel history, pink for travel history to Wuhan <14 days from symptom onset, orange for travel history to other regions in mainland China, and green for travel history to regions outside mainland China. Contact histories are highlighted by red lines for family contacts and green lines for nonfamily contacts. Case numbers are those used by the Centre of Health Protection, Department of Health, Hong Kong (6). Within each cluster, cases of primary infection (leftmost column) are arranged from top to bottom in order of the date (DD/MM) of symptom onset. SSE, superspreading event.

Figure 1. Demographics of coronavirus disease patients, Hong Kong, February 2020. Rectangular boxes indicate men or boys and stadium-shaped boxes indicate women or girls. Travel history within the 14-day incubation period before symptom onset is highlighted in cyan for local case without travel history, pink for travel history to Wuhan <14 days from symptom onset, orange for travel history to other regions in mainland China, and green for travel history to regions outside mainland China. Contact histories are highlighted by red lines for family contacts and green lines for nonfamily contacts. Case numbers are those used by the Centre of Health Protection, Department of Health, Hong Kong (6). Within each cluster, cases of primary infection (leftmost column) are arranged from top to bottom in order of the date (DD/MM) of symptom onset. SSE, superspreading event.

Main Article

References
  1. Zhu  N, Zhang  D, Wang  W, Li  X, Yang  B, Song  J, et al.; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33. DOIPubMedGoogle Scholar
  2. Guan  WJ, Ni  ZY, Hu  Y, Liang  WH, Ou  CQ, He  JX, et al.; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708–20. DOIPubMedGoogle Scholar
  3. Chan  JF, Yuan  S, Kok  KH, To  KK, Chu  H, Yang  J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–23. DOIPubMedGoogle Scholar
  4. Li  Q, Guan  X, Wu  P, Wang  X, Zhou  L, Tong  Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–207. DOIPubMedGoogle Scholar
  5. Dong  E, Du  H, Gardner  L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533–4. DOIPubMedGoogle Scholar
  6. Centre for Health Protection. Latest local situation of severe respiratory disease associated with a novel infectious agent. 2020 [cited 2020 Feb 24]. https://chp-dashboard.geodata.gov.hk/covid-19/en.html
  7. Leung  YF, Wong  HB, Shing  Y, Wong  HW, Wong  WK. COVID-19 in HK. 2020 [cited 2020 Feb 25]. https://wars.vote4.hk
  8. Centre for Health Protection. Severe respiratory disease associated with a novel infectious agent—letters to doctors. 2020 [cited 2020 Feb 6]. https://www.chp.gov.hk/files/pdf/letters_to_doctors_20200107.pdf
  9. Corman  VM, Landt  O, Kaiser  M, Molenkamp  R, Meijer  A, Chu  DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25:25. DOIPubMedGoogle Scholar
  10. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. 2020 [cited 2020 Jan 11]. https://www.who.int/publications/i/item/clinical-management-of-covid-19
  11. Peiris  JS, Lai  ST, Poon  LL, Guan  Y, Yam  LY, Lim  W, et al.; SARS study group. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–25. DOIPubMedGoogle Scholar
  12. Quick  J. Artic Network-nCoV 2019 sequencing protocol. 2020 [cited 2020 Feb 24]. https://artic.network/ncov-2019
  13. Loman  N, Rambaut  A. nCoV-2019 novel coronavirus bioinformatics protocol. [cited 2020 Mar 10]. https://artic.network/ncov-2019/ncov2019-bioinformatics-sop.html
  14. DePristo  MA, Banks  E, Poplin  R, Garimella  KV, Maguire  JR, Hartl  C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43:491–8. DOIPubMedGoogle Scholar
  15. Guindon  S, Dufayard  JF, Lefort  V, Anisimova  M, Hordijk  W, Gascuel  O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59:307–21. DOIPubMedGoogle Scholar
  16. Elbe  S, Buckland-Merrett  G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Glob Chall. 2017;1:33–46. DOIPubMedGoogle Scholar
  17. Bouckaert  R, Heled  J, Kühnert  D, Vaughan  T, Wu  CH, Xie  D, et al. BEAST 2: a software platform for Bayesian evolutionary analysis. PLOS Comput Biol. 2014;10:e1003537. DOIPubMedGoogle Scholar
  18. Rambaut  A, Drummond  AJ, Xie  D, Baele  G, Suchard  MA. Posterior summarization in Bayesian phylogenetics ssing Tracer 1.7. Syst Biol. 2018;67:901–4. DOIPubMedGoogle Scholar
  19. Chen  N, Zhou  M, Dong  X, Qu  J, Gong  F, Han  Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13. DOIPubMedGoogle Scholar
  20. Huang  C, Wang  Y, Li  X, Ren  L, Zhao  J, Hu  Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. DOIPubMedGoogle Scholar
  21. Wang  D, Hu  B, Hu  C, Zhu  F, Liu  X, Zhang  J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–9. DOIPubMedGoogle Scholar
  22. Wu  J, Liu  J, Zhao  X, Liu  C, Wang  W, Wang  D, et al. Clinical characteristics of imported cases of COVID-19 in Jiangsu Province: a multicenter descriptive study. Clin Infect Dis. 2020;71:706–12. DOIPubMedGoogle Scholar
  23. Boskova  V, Stadler  T, Magnus  C. The influence of phylodynamic model specifications on parameter estimates of the Zika virus epidemic. Virus Evol. 2018;4:vex044. DOIPubMedGoogle Scholar
  24. Lai  A, Bergna  A, Acciarri  C, Galli  M, Zehender  G. Early phylogenetic estimate of the effective reproduction number of SARS-CoV-2. J Med Virol. 2020;92:675–9. DOIPubMedGoogle Scholar
  25. Sung  AD, Sung  JAM, Thomas  S, Hyslop  T, Gasparetto  C, Long  G, et al. Universal mask usage for reduction of respiratory viral infections after stem cell transplant: a prospective trial. Clin Infect Dis. 2016;63:999–1006. DOIPubMedGoogle Scholar
  26. Seto  WH, Tsang  D, Yung  RW, Ching  TY, Ng  TK, Ho  M, et al.; Advisors of Expert SARS group of Hospital Authority. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet. 2003;361:1519–20. DOIPubMedGoogle Scholar

Main Article

Page created: November 23, 2020
Page updated: December 21, 2020
Page reviewed: December 21, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external